Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers.

Milewska, Malgorzata; Cremona, Mattia; Morgan, Clare; O'Shea, John; Carr, Aoife; Vellanki, Sri H; Hopkins, Ann M; Toomey, Sinead; Madden, Stephen F; Hennessy, Bryan T; Eustace, Alex J

Milewska, Malgorzata; Cremona, Mattia; Morgan, Clare; O'Shea, John; Carr, Aoife; Vellanki, Sri H; Hopkins, Ann M; Toomey, Sinead; Madden, Stephen F; Hennessy, Bryan T; Eustace, Alex J.

Afiliação

Milewska M; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Cremona M; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Morgan C; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
O'Shea J; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Carr A; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Vellanki SH; Department of Surgery, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Hopkins AM; Department of Surgery, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.
Madden SF; Data Science Centre Royal College of Surgeons in Ireland, Ireland.
Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Ireland.
Eustace AJ; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin, 9, Ireland.